You Can See The Diarrhea in YUM! Brands Third Quarter
YUM! Brands reported a 4% drop in Taco Bell's same-store sales in Q3 due to a Cyclospora outbreak, while overall same-store sales were flat. Adjusted earnings beat estimates at $1.56 per share, and revenue matched at $2.05 billion. Q4 same-store sales are up 1%, with KFC's U.S. sales down 6%. CEO Turner aims to modernize KFC.
How this was made

The 30-second read
Why it matters
Earnings beat and pre‑market rally suggest short‑term buying interest, but the same‑store sales decline at Taco Bell may limit upside.
Market read
YUM’s earnings beat provides a modest trade opportunity; the health incident is a localized risk.
What to watch
Potential ongoing supply‑chain scrutiny and health‑safety costs could affect future margins.
Background
Yum! Brands reported Q3 results with adjusted EPS $1.56 vs $1.49 estimate, revenue $2.05B in line, and a 2% pre‑market share rise after a food‑borne illness issue at Taco Bell.
Ticker impact
Q3 earnings beat expectations and shares rose >2% pre‑open after a diarrhea outbreak at Taco Bell hurt same‑store sales.
likely modest upside as market prices in the earnings beat and pre‑market rally.
The beat and pre‑market price move are fresh, material data for a large cap.
Market effects
Fast‑food sector may see mixed reactions as Taco Bell’s issue is isolated, while overall Q3 earnings beat supports consumer discretionary sentiment.
U.S. markets may see a slight lift in restaurant stocks, but limited broader impact.
Limited; primarily U.S. equity focus.
Counterpoint
The sales dip from the parasite outbreak could signal lingering consumer concerns, potentially weighing on YUM longer term.
Key entities
- CompanyYum! Brands
Parent of Taco Bell, KFC, Pizza Hut.



